Many neurologic complications have been described after severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) including atypical cases of optic neuritis (ON), positive to myelin oligodendrocyte glycoprotein (MOG) IgG.
Objective
To report a case of MOG-IgG-associated ON and discuss why SARS-CoV-2 infection could be a potential trigger.
Methods
Retrospective single case report.
Results
We report a case of ON with positive MOG-IgG developed 15 days after presentation of SARS-CoV-2 infection.
Conclusion
This report suggests that SARS-CoV-2 infection may have triggered autoantibodies production against MOG leading to ON.
GuanW-JNiZ-YHuY, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med2020; 382: 1708–1720.
2.
HelmsJKremerSMerdjiH, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med2020; 382: 2268–2270.
3.
ChenJJPittockSJFlanaganEP, et al. Optic neuritis in the era of biomarkers. Surv Ophthalmol2020; 65: 12–17.
4.
WeberMSDerfussTMetzI, et al. Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord2018; 11: 1756286418762083.
5.
ChenJJFlanaganEPJitprapaikulsanJ, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol2018; 195: 8–15.
LiYCBaiWZHashikawaT. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92: 552–555.
8.
VargaZFlammerAJSteigerP, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395: 1417–1418.
9.
IdeTKawanamiTEriguchiM, et al. SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: a case report and literature review. Intern Med. 2022; 61: 1253–1258.
10.
MariottoSCartaSDinotoA, et al. Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?Eur J Neurol. 2022; 29: 1855–1858.
11.
JohnssonMAsztelyFHejneboS, et al. SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder. Ann Clin Transl Neurol. 2022; 9: 1296–1301.
12.
LambeJMcGinleyMPMossBP, et al. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: a case series. Neuroimmunol. 2022; 370: 577933. Epub 2022 Jul 14.
13.
SawalhaKAdeodokunSKamogaG-R. COVID-19-induced acute bilateral optic neuritis. J Investig Med High Impact Case Rep2020; 8: 2324709620976018.
14.
ZhouSJones-LopezECSonejiDJ, et al. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19. J Neuroophthalmol2020; 40: 398–402.
15.
WoodhallMMitchellJWGibbonsE, et al. Case report: myelin oligodendrocyte glycoprotein antibody-associated relapse with COVID-19. Front Neurol2020; 11: 598531.
16.
NakamuraMIwasakiYTakahashiT, et al. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. Mult Scler Relat Disord2017; 17: 148–150.
